Abstract
This study investigates shifts in antibiotic prescribing practices in a UK secondary care setting during the COVID-19 pandemic, highlighting implications for antimicrobial resistance (AMR). Using data from 640 patient records, it compares antibiotic use before and during the pandemic, with findings showing a notable increase in "Watch" category antibiotics, such as azithromycin and clarithromycin, and a doubling in levofloxacin use. These trends underscore the need for stringent antimicrobial stewardship (AMS) to ensure responsible prescribing. The study stresses the importance of enhanced AMS practices and sustained monitoring efforts to address AMR effectively and safeguard patient outcomes during health crises.
| Original language | English |
|---|---|
| Publication status | Published - 8 Nov 2024 |
| Event | Royal pharmaceutical society annual conference 2024: Working across boundaries: Embracing new opportunities and empowering excellence - Convene, 133 Houndsditch, London, United Kingdom Duration: 8 Nov 2024 → 8 Nov 2024 |
Conference
| Conference | Royal pharmaceutical society annual conference 2024 |
|---|---|
| Country/Territory | United Kingdom |
| City | London |
| Period | 8/11/24 → 8/11/24 |
Keywords
- antimicrobial resistance (AMR)
- antimicrobial resistance
- Antimicrobial Classification
- Antimicrobial properties
- antimicrobial cultures
- antimicrobial efficacy
- Pattern
- trends
- Antimicrobial Stewardship (AMS)
- Antimicrobial stewardship
- COVID-19 Pandemic
- COVID-19
- antibiotic prescribing
- Secondary care
- Secondary Care Setting
- Defined daily dose (DDD)
- Defined daily dose
- WHO AWaRe Classification
- WHO criteria
- WHO
- Levofloxacin
- patient safety; incident reporting
- patient safety
- Health crisis management
- emergency care
- emergency preparedness
- Azithromycin
- CIPROFLOXACIN
- Co-amoxiclav
- Amoxiclav
- Amoxicillin